Skip to main content
. 2022 Jun 4;14(11):2796. doi: 10.3390/cancers14112796

Figure 1.

Figure 1

Kinetics of neutralizing antibodies (NAbs) in cancer patients receiving immunotherapy and matched controls at several timepoints after COVID-19 vaccination. The asterisk (★) denotes a statistically significant difference between the sixth month levels and the previous timepoints (p < 0.01).